Home » Headlines » Currently Reading:

Morning Headlines 2/13/13

February 12, 2013 Headlines No Comments

Greenway Reports Fiscal 2013 Second-Quarter Results, Revises Outlook for Fiscal 2013

Greenway announces Q2 results: revenue up 12 percent, EPS $0.00 far short of analyst estimates of $0.05.  Greenway has adjusted FY13 earnings guidance to $0.21-$0.28 EPS, with analysts predicting $0.27. Shares were down eight percent in Tuesday’s after-hours trading.

RazorInsights Secures $11 Million from Bluff Point Associates

Following a strong reception into the critical access and community hospital EHR market, RazorInsight closes an $11 Million in Series A funding round.

Branzell named CEO of CHIME

Russell Branzell, CEO of the Colorado Health Medical Group, has been named president and CEO of CHIME.

Electronic Medical Records at The Mount Sinai Medical Center Shown to Greatly Improve Quality of Care

Mount Sinai’s ongoing $120 million Epic implementation is credited with improved core measure performance and a reduction of readmissions by 56 percent.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Just a Reader: Continuing the blockchain conversation that @DrM and @dysF(n) started on this comments page... I understand how block...
  • HIT Girl: I think I'm going to start applying for random C-level positions now. I won't even bother to read the job description, ...
  • Really???: Getting very Alice-In-Wonderland-y in Trumpville methinks....
  • Epic Employee: Self-scheduling is definitly out there. I personally schedule all my primary care visits through MyChart either on the w...
  • ex-HHC: re:GIFT trial and Coumadin dosing. Medicare wouldn't pay for warfarin-based genotyping and this trial doesnt really seem...

Sponsor Quick Links